✦ LIBER ✦

CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasia

✍ Scribed by Tayeb, M T; Clark, C; Haites, N E; Sharp, L; Murray, G I; McLeod, H L

Book ID: 109997515
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 96 KB
Volume: 88
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6600825

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CYP17 polymorphisms in relation to risks

CYP17 polymorphisms in relation to risks of prostate cancer and benign prostatic hyperplasia: A population-based study in China

✍ M. Patricia Madigan; Yu-Tang Gao; Jie Deng; Ruth M. Pfeiffer; Bao-Li Chang; Siqu 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 78 KB 👁 1 views

## Abstract Because androgens likely play a key role in prostate growth and prostate cancer development, variants of genes involved in androgen biosynthesis may be related to prostate cancer risk. The enzyme P450c17α, encoded by the __CYP17__ gene, catalyzes the conversion of progesterone and pregn

Prostate tissue and leukocyte levels of

Prostate tissue and leukocyte levels of n-3 polyunsaturated fatty acids in men with benign prostate hyperplasia or prostate cancer

✍ JEPPE HAGSTRUP CHRISTENSEN; KNUD FABRIN; KIRSTEN BORUP; NEIL BARBER; JOHAN POULS 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

Two-dimensional electrophoresis of prost

Two-dimensional electrophoresis of prostate-specific antigen in sera of men with prostate cancer or benign prostate hyperplasia

✍ Jean-Philippe Charrier; Carole Tournel; Sandrine Michel; Pascal Dalbon; Michel J 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 156 KB 👁 2 views

Two-dimensional electrophoresis of prostatespecific antigen in sera of men with prostate cancer or benign prostate hyperplasia Prostate-specific antigen (PSA), the main marker for prostate cancer (PCa), is released from the prostate into the blood stream at nanogram level and may increase in PCa and

Polymorphisms of fibroblast growth facto

Polymorphisms of fibroblast growth factor receptor 4 have association with the development of prostate cancer and benign prostatic hyperplasia and the progression of prostate cancer in a Japanese population

✍ Zhiyong Ma; Norihiko Tsuchiya; Takeshi Yuasa; Takamitsu Inoue; Teruaki Kumazawa; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 French ⚖ 138 KB 👁 1 views

## Abstract Fibroblast growth factor receptor 4 (FGFR4) is a member of a family of transmembrane receptors with ligand‐induced tyrosine kinase activity. The Glycine (Gly) to Arginine (Arg) polymorphism at codon 388 (Gly388Arg), which encodes an amino acid in the transmembrane part of the FGFR4 gene

Family history of cancer and the risk of

Family history of cancer and the risk of prostate cancer and benign prostatic hyperplasia

✍ Eva Negri; Claudio Pelucchi; Renato Talamini; Maurizio Montella; Silvano Gallus; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 76 KB 👁 2 views

## Abstract We analysed the relation between family history of cancer in first‐degree relatives and risk of prostate cancer (PC) and benign prostatic hyperplasia (BPH) using data from a multicentric case‐control study conducted in Italy from 1991 to 2002 on 1,294 cases of incident, histologically c

Association of vitamin D receptor gene p

Association of vitamin D receptor gene polymorphism with protection against prostate cancer and benign prostate hyperplasia

✍ Ogawa, O; Suzuki, T; Habuchi, T; Sasaki, R; Tachiki, Y; Akao, T; Tsuchiya, N; Ka 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 38 KB